Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Observational × Pyridostigmine Bromide × Clear all

Status

Sponsor Class

INDIV 2 OTHER 1

Study Type

Interventional 5 Observational 1

Sponsor

Conditions

Myasthenia Gravis 1

Interventions

Surveys and Questionnaires 449 Blood Specimen Collection 343 Surgical Procedures, Operative 128 Radiotherapy 119 Interviews as Topic 117 Drug Therapy 106 Observation 97 Magnetic Resonance Spectroscopy 91 Biopsy 89 Specimen Handling 62 Data Collection 60 Neoadjuvant Therapy 59 Magnetic Resonance Imaging 56 Immunohistochemistry 53 Immune Checkpoint Inhibitors 50 Watchful Waiting 46 Positron Emission Tomography Computed Tomography 40 Bevacizumab 40 Ultrasonography 38 Liquid Biopsy 38 Radiosurgery 37 pembrolizumab 35 Therapeutics 35 Gene Expression Profiling 35 Hematologic Tests 34 Immunotherapy 33 Tomography, X-Ray Computed 32 Focus Groups 32 Colonoscopy 32 High-Energy Shock Waves 30

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04182984 2026-01-30

TREAT-OMG

Tang-Du Hospital

Myasthenia Gravis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡